SCHEMBL365115

SCHEMBL365115

CS(=O)(=O)NC(=O)c1ccc(COc2cccc(Cl)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.64
RXRB P28702 1/20 0.64
RXRG P48443 1/20 0.64
SCN9A Q15858 1/20 0.56
BCL2L1 Q07817 6/20 0.55
MCL1 Q07820 6/20 0.55
SMPD1 P17405 3/20 0.54
MAOA P21397 3/20 0.53
MAOB P27338 3/20 0.53
NPC1 O15118 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
RAB9A P51151 1/20 0.52
SLC6A5 Q9Y345 1/20 0.52
NR4A2 P43354 2/20 0.51
MRGPRX4 Q96LA9 1/20 0.50
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL16239962 0.94 RXRA (0.58) RXRARXRBRXRGSCN9ABCL2L1
SCHEMBL365474 0.88 MAOB (0.67) RXRARXRBRXRGBCL2L1MCL1
SCHEMBL364835 0.86 SMPD1 (0.60) SCN9ABCL2L1MCL1SMPD1MAOB
SCHEMBL20773035 0.85 SMPD1 (0.58) SCN9ABCL2L1MCL1SMPD1MAOA
SCHEMBL366081 0.85 MAOA (0.63) SCN9ABCL2L1MCL1MAOAMAOB
SCHEMBL365210 0.85 MAOA (0.63) SCN9ABCL2L1MCL1MAOAMAOB
SCHEMBL16240196 0.84 SCN9A (0.77) SCN9ABCL2L1MCL1SLC6A5MRGPRX4
SCHEMBL365207 0.83 SCN9A (0.51) RXRARXRBRXRGSCN9ABCL2L1
SCHEMBL678903 0.82 BCL2L1 (0.52) SCN9ABCL2L1MCL1NPC1RAB9A
Diethylamine SCHEMBL14890330 0.81 SMPD1 (0.55) SCN9ABCL2L1MCL1SMPD1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2593428-A2 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS Pfizer Limited (GB) 2013-05-22 EP disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012007868-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A RXRA 1658/4885RXRB 1975/4885RXRG 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.